Key facts
| Price (PPV) | 12,836 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | carfilzomib |
| Class | Antineoplastic agents |
| ATC code | L01XX45 |
| Manufacturer | AMANYS PHARMA (Ex SAHAM PHARMA) |
| Presentation | Boite de 1 flacon |
| Nature | Médicament |
| Hospital price | 12,592 MAD |
| Data collected on | 9/8/2026 |
Indications
Kyprolis en association avec le daratumumab et la dexaméthasone, avec le lénalidomide et la dexaméthasone, ou avec la dexaméthasone seule, est indiqué dans le traitement du myélome multiple chez les patients adultes qui ont reçu au moins un traitement antérieur.
Find an open pharmacy
On-call pharmacies near you
About Kyprolis 60 mg
Kyprolis 60 mg belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by AMANYS PHARMA (Ex SAHAM PHARMA) and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Kyprolis 60 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Kyprolis 60 mg
Answers to common questions from Moroccan patients about this drug.